Physiologically‐based pharmacokinetic modeling for primary metabolites of CYP3A and P‐glycoprotein inhibitors in drug–drug interactions: Should we assume the free drug hypothesis?

Detalles Bibliográficos
Autores principales: Yamazaki, Shinji, Evers, Raymond, De Zwart, Loeckie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835114/
https://www.ncbi.nlm.nih.gov/pubmed/36369633
http://dx.doi.org/10.1002/psp4.12879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835114/
https://www.ncbi.nlm.nih.gov/pubmed/36369633
http://dx.doi.org/10.1002/psp4.12879

Ejemplares similares